BBOT
Financials
- Market Capitalization 691.32 M
- Employee 106
- Founded 2016
- CEO N/A
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG01L3GYF02
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2711 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 6.47 USD | +0.31% | +3.85% | -3.00% | +960.66% | 678.64 M USD | ||
| 2715 |  MNPR Monopar Therapeutics Inc. - Common Stock | 104.42 USD | +1.05% | +7.41% | +72.60% | +91.18% | 699.52 M USD | ||
| 2736 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 1.92 USD | -0.52% | -9.86% | -0.52% | +48.84% | 662.70 M USD | ||
| 2739 |  PTCT PTC Therapeutics, Inc. - Common Stock | 79.98 USD | -1.66% | -8.37% | +11.04% | +61.77% | 663.43 M USD |
Frequently asked questions about BridgeBio Oncology Therapeutics, Inc. - Common Stock
What is the BridgeBio Oncology Therapeutics, Inc. - Common Stock stock price today?
The current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT) is 8.63. Over the past 24 hours, the stock has changed by +1.29%. Follow the BBOT chart for real-time price dynamics.
What is the stock ticker of BridgeBio Oncology Therapeutics, Inc. - Common Stock?
BridgeBio Oncology Therapeutics, Inc. - Common Stock trades under the ticker BBOT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BridgeBio Oncology Therapeutics, Inc. - Common Stock stock going up?
BBOT has changed by +3.73% over the last week, +10.64% over the last month, and -9.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BridgeBio Oncology Therapeutics, Inc. - Common Stock net income for the last quarter?
BridgeBio Oncology Therapeutics, Inc. - Common Stock reported net income of -42.11 M for the last quarter. The previous quarter showed -38.8 M, which means net income changed by -8.53%.
How many employees does BridgeBio Oncology Therapeutics, Inc. - Common Stock have?
As of the latest available data, BridgeBio Oncology Therapeutics, Inc. - Common Stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is BridgeBio Oncology Therapeutics, Inc. - Common Stock EBITDA?
BridgeBio Oncology Therapeutics, Inc. - Common Stock EBITDA is -42.12 M, and its EBITDA margin is -1 068.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BridgeBio Oncology Therapeutics, Inc. - Common Stock stock?
You can buy BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BridgeBio Oncology Therapeutics, Inc. - Common Stock stock?
Investing in BridgeBio Oncology Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BBOT chart and related analysis on metatrader.com as part of your research.